Lukas Huber studied medicine at the University of Innsbruck. He joined the laboratory of Kai Simons at EMBL in Heidelberg (Germany) as postdoc in epithelial biology until 1994. He then moved to the University of Geneva (Switzerland) and worked in the laboratory of Jean Gruenberg on endocytosis in epithelial cells. In 1996, he started his own laboratory at the I.M.P. in Vienna (Austria) and in 2002 he got appointed as Professor and Head of Cell Biology and scientific director of the Biocenter of Innsbruck Medical University (Austria). His research interests have expanded to understanding the spatial and temporal resolution of signalling mechanisms mammalian cells applying molecular cell biology, mouse genetics and functional proteomics. He initiated and coordinates the Austrian Proteomics Platform of the Austrian Genome Program (GEN-AU) and a special research program in Innsbruck entitled “Cell proliferation and Cell Death in Tumors –SFB021” of the Austrian Science Fund (FWF).
http://www.i-med.ac.at/biocenter/

Professional Experience:

Visiting Student 1988-89, DKFZ, German Cancer Research Centre, Heidelberg, Institute for Radiology and Pathophysiology, Prof. Dr. W. Friedrich and Lipid Research Group, University of Heidelberg PD Dr.Dr. Hans Alois Dresel

Visiting Student 1989, Böhringer Mannheim, Atherosclerosis and Bone Marrow Metabolism, Scientific Director, PD Dr.Dr. Hans Alois Dresel

Univ.-Assistant 1990, Institute for General and Experimental Pathology, University of Innsbruck, Medical School, Prof. Dr. Georg Wick

Postdoctoral Fellow 1990-93, European Molecular Biology Laboratory (EMBL), Cell Biology Program, Heidelberg, Prof. Dr. Kai Simons

Maître Assistant 1994-96, Département de Biochimie, Université de Géneve, Sciences II, Genève, Switzerland, Prof. Dr. Jean Gruenberg

Group Leader 1996-2002, IMP, Institute of Molecular Pathology, Vienna, Austria

Full Professor at Innsbruck Medical University since 2002,

Scientific Director Biocenter,since 2005

Director Division Cell Biology since 2005

Co-Director of the Integrated Therapy and Research Center (IFTZ) at Innsbruck Medical University since 2007

Editorial:

Editor, since September 2003, FEBS Letters

Associate Editor since 1997, Electrophoresis, Wiley-VCH

Guest Editor 1998-00, Protoplasma, Springer Vienna (MiniReview section)

Senior Editor since 2001, Proteomics, Wiley-VCH (Inauguration 01/2001)

Section Editor since 2000, Current Opinion in Molecular Therapeutics, Current Biology Publications

Associate Editor since 2001,Journal of Mammary Gland Biology and Neoplasia

Associate Editor since 2002, Histochemistry and Cell Biology

Reviewing: Nature, Science, Cell, Dev. Cell, PNAS, EMBO J., J. Cell Biology, Traffic, FEBS Letters (incl. book reviews), Electrophoresis, Proteomics, Molecular and Cellular proteomics, J Proteome Research, European. J. Biology, J. Exp. Cell Research, Current Opinion in Molecular Therapeutics etc.

Special Training: Leadership Course for Senior Executives 1996, Boehringer Ingelheim Cooperation "The Challenge of World Class Leadership", at IMD, International Institute for Management Development, Lausanne, Switzerland.

Advisory Board (presently active): BAYGENE, Bavarian Genome Network

Scientific Coordination:

Speaker of the Austrian Proteomics Platform, Austrian Genome Program, GEN-AU (2003-2012)

Speaker of a Special Research Program at the University of Innsbruck “Cell Proliferation and Cell Death in Tumors” (SFB021) (2003-2013)

Coordinator of FP6 (STREP) GROWTHSTOP

Co-Director of the Integrated Therapy and Research Center (IFTZ): Innsbruck Medical University (2007-2008)

CSO, Center for Personalized Cancer medicine, ONCOTYROL, Innsbruck, Austria (since 2009)